GSK

Golfer devastated after just barely missing a putt
Biotech

GSK anti-TIM-3 antibody flunks ph. 3, as TIGIT fail costs $629M

GSK’s cobolimab has become the latest anti-TIM-3 antibody to flunk a crucial oncology test.
James Waldron Jul 30, 2025 5:27am
Lung

GSK strengthens COPD offering via $12B biobucks Hengrui deal

Jul 28, 2025 4:36am
team layoffs workforce

GSK plans 'very limited' job cuts for global R&D team

Jul 15, 2025 4:15pm
Alps parachute rainbow mountains

Sanofi vaccine vet vaults to GSK—Chutes & Ladders

Jun 13, 2025 8:30am
Graphic showing arrows missing the bullseye on a target

How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble

Jun 13, 2025 8:00am
pass the torch deal sell buy acquisition

GSK offloads shigella vaccine to Bharat ahead of phase 3

Jun 12, 2025 9:18am